Patents-Review.com
🔗 Permalink
Assignee profile:

ASCENEURON SA

City:

Lausanne

Country:

Switzerland

Published Applications:

18

Last publication date:

2023-04-20

Patent Grants:

18

Last grant date:

2025-08-26

Top Inventors for applications by ASCENEURON SA

These are the the leading inventors for applications assigned to ASCENEURON SA:

Recent patent applications by ASCENEURON SA

ASCENEURON SA based in Lausanne, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-04-20 ✅ Patent 12,398,130 granted on 2025-08-26
US20230120169A1
Chemistry; metallurgy

ACID ADDITION SALTS OF PIPERAZINE DERIVATIVES

 #2 | 2022-12-29 ✅ Patent 12,187,741 granted on 2025-01-07
US20220411440A1
Chemistry; metallurgy

Glycosidase inhibitors

 #3 | 2022-12-01 ✅ Patent 11,795,165 granted on 2023-10-24
US20220380358A1
Chemistry; metallurgy

Tetrahydro-benzoazepine glycosidase inhibitors

 #4 | 2022-06-09 ✅ Patent 12,157,734 granted on 2024-12-03
US20220177470A1
Chemistry; metallurgy

Sulfoximine glycosidase inhibitors

 #5 | 2021-07-15 ✅ Patent 12,016,852 granted on 2024-06-25
US20210213005A1
Human necessities

Pyrrolidine glycosidase inhibitors

 #6 | 2021-07-08 ✅ Patent 11,731,972 granted on 2023-08-22
US20210206766A1
Chemistry; metallurgy

Spiro compounds as glycosidase inhibitors

 #7 | 2021-07-01 ✅ Patent 12,195,455 granted on 2025-01-14
US20210198250A1
Chemistry; metallurgy

Succinate and fumarate acid addition salts of piperazine derivatives

 #8 | 2021-06-24 ✅ Patent 11,612,599 granted on 2023-03-28
US20210186958A1
Human necessities

Glycosidase inhibitors

 #9 | 2021-03-18 ✅ Patent 11,213,525 granted on 2022-01-04
US20210077488A1
Human necessities

Linear glycosidase inhibitors

 #10 | 2020-12-10 ✅ Patent 11,591,327 granted on 2023-02-28
US20200385375A1
Chemistry; metallurgy

Acid addition salts of piperazine derivatives

 #11 | 2020-09-17 ✅ Patent 11,458,140 granted on 2022-10-04
US20200289516A1
Human necessities

Annulated glycosidase inhibitors

 #12 | 2020-01-02 ✅ Patent 11,261,183 granted on 2022-03-01
US20200002326A1
Chemistry; metallurgy

Sulfoximine glycosidase inhibitors

 #13 | 2019-12-26 ✅ Patent 10,995,090 granted on 2021-05-04
US20190388415A1
Human necessities

Substituted dihydrobenzofuran glycosidase inhibitors

 #14 | 2019-12-05 ✅ Patent 11,046,712 granted on 2021-06-29
US20190367533A1
Chemistry; metallurgy

Glycosidase inhibitors

 #15 | 2019-02-21 ✅ Patent 10,556,902 granted on 2020-02-11
US20190055239A1
Chemistry; metallurgy

Glycosidase inhibitors

 #16 | 2019-02-21 ✅ Patent 10,696,668 granted on 2020-06-30
US20190055233A1
Chemistry; metallurgy

Acid addition salts of piperazine derivatives

 #17 | 2017-10-19 ✅ Patent 10,336,775 granted on 2019-07-02
US20170298082A1
Chemistry; metallurgy

Glycosidase inhibitors

 #18 | 2016-05-19 ✅ Patent 9,505,769 granted on 2016-11-29
US20160137648A1
Chemistry; metallurgy

Tetraaza-cyclopenta[a]indenyl derivatives

Also check out Asceneuron SA's (Lausanne, Switzerland) applicant profile with 21 patent applications submitted.

AssigneeID:

108389 ⎘